| |
| |
| Exchange: |
OTC Bulletin Board |
| Security
Type: |
Common |
| Shares
Out: |
31,570,000 |
| Market
Cap: |
15.79(M) |
| Last
Volume: |
540,567 |
Avg
Vol: |
539,072 |
| 52
Week Range: |
$0.1483 - $3.06 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile BrainStorm Cell Therapeutics is a biotechnology company engaged in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases including: Amyotrophic Lateral Sclerosis; Progressive Multiple Sclerosis; Alzheimer's disease; and other neurodegenerative diseases. NurOwn®, Co.'s proprietary platform, utilizes cell culture methods to induce autologous bone marrow-derived mesenchymal stem cells to secrete neurotrophic factors, modulate neuroinflammatory and neurodegenerative disease processes, promote neuronal survival and improve neurological function.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
11,500 |
11,500 |
| Total Buy Value |
$0 |
$0 |
$20,402 |
$20,402 |
| Total People Bought |
0 |
0 |
1 |
1 |
| Total Buy Transactions |
0 |
0 |
1 |
1 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-15 |
2023-11-14 |
2023-05-16 |
2022-05-16 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Frankenberger Mike |
Former Director and Officer |
– – – |
2004-08-01 |
4 |
B |
$0.01 |
$200 |
D/D |
20,000 |
140,000 |
2.36 |
- |
|
| Zegal & Ross Capital Llc |
10% Owner |
– – • |
2004-07-14 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
2,600,000 |
|
- |
|
| Frankenberger Mike |
Director |
– • • |
2004-05-21 |
4 |
D |
$0.02 |
$160,304 |
D/D |
(6,880,000) |
120,000 |
|
- |
|
| Arbel Irit |
PresidentOfficer |
• • • |
2004-05-21 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
2,300,000 |
|
- |
|
| Frankenberger Mike |
Director |
– • • |
2004-05-20 |
4 |
A |
$0.01 |
$600 |
D/D |
100,000 |
7,000,000 |
|
- |
|
| Frankenberger Mike |
Former Director and Officer |
– – – |
2004-04-28 |
4 |
S |
$0.02 |
$158,240 |
D/D |
(6,880,000) |
120,000 |
|
- |
|
| Frankenberger Mike |
Former Director and Officer |
– – – |
2004-02-20 |
4 |
B |
$0.01 |
$1,000 |
D/D |
100,000 |
7,000,000 |
2.36 |
- |
|
| Frankenberger Mike |
Former Director and Officer |
– – – |
2003-12-30 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,562,000) |
6,900,000 |
|
- |
|
| Frankenberger Mike |
Former Director and Officer |
– – – |
2003-12-05 |
4 |
D |
$0.00 |
$0 |
D/D |
(8,500,000) |
8,462,000 |
|
- |
|
| Frankenberger Mike |
President, CEO, CFO |
• • • |
2003-10-21 |
4 |
S |
$1.15 |
$43,700 |
D/D |
(38,000) |
16,962,000 |
|
- |
|
| Frankenberger Mike |
President, CEOOfficer |
• • • |
2001-09-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
8,500,000 |
|
- |
|
211 Records found
|
|
Page 9 of 9 |
|
|
0.05 (8.74%) 
